Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. (Q40715769)
Jump to navigation
Jump to search
scientific article published on April 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. |
scientific article published on April 2001 |
Statements
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma (English)
G K Schwartz
D Ilson
L Saltz
W Tong
J Werner
P Perkins
M Stoltz